Vanguard Group Inc Codexis, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding CDXS
# of Institutions
140Shares Held
63.3MCall Options Held
37.7KPut Options Held
25.9K-
Opaleye Management Inc. Boston, MA9.5MShares$27.4 Million7.03% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$23.3 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$19.6 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$8.64 Million1.17% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.83MShares$8.15 Million0.34% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $189M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...